MindMaze Therapeutics develops precision neurotherapeutic solutions that combine behavioral programs, software, connected devices, and data to treat and manage neurological disease and improve brain health. The company builds clinically validated treatment ecosystems intended to accelerate recovery, enable at‑home and in‑clinic therapy, and generate digital biomarkers to guide personalized care.

We deliver a portfolio of products and services across a treatment platform, therapy & monitoring, and drug development for rare neurological conditions. Their commercially available solutions—such as MindPod, MindMotion GO, Izar, and Physilog—are designed to restore motor and cognitive function through immersive, engaging rehabilitation, remote monitoring, and advanced motion analytics.

MindMaze focuses on translating deep-technology research into clinically effective neurotherapeutics, partnering with hospitals and research centers worldwide to run clinical trials, deploy treatments, and collect real-world data to continuously improve outcomes.